(EG) Everest - Ratings and Ratios

Exchange: NYSE • Country: Bermuda • Currency: USD • Type: Common Stock • ISIN: BMG3223R1088

Reinsurance, Property Casualty Insurance, Commercial Insurance

EG EPS (Earnings per Share)

EPS (Earnings per Share) of EG over the last years for every Quarter: "2020-03": 0.41, "2020-06": 4.83, "2020-09": 6.14, "2020-12": 1.61, "2021-03": 8.63, "2021-06": 17.19, "2021-09": -1.87, "2021-12": 10.99, "2022-03": 7.67, "2022-06": 3.11, "2022-09": -8.22, "2022-12": 12.72, "2023-03": 9.43, "2023-06": 16.46, "2023-09": 15.8, "2023-12": 18.53, "2024-03": 17.09, "2024-06": 16.92, "2024-09": 11.95, "2024-12": -13.89, "2025-03": 4.92,

EG Revenue

Revenue of EG over the last years for every Quarter: 2020-03: 1982.016, 2020-06: 2244.515, 2020-09: 2610.184, 2020-12: 2670.638, 2021-03: 2743.773, 2021-06: 2836.724, 2021-09: 2786.705, 2021-12: 3048.129, 2022-03: 2896.331, 2022-06: 2834.613, 2022-09: 3115, 2022-12: 3274, 2023-03: 3286, 2023-06: 3651, 2023-09: 3991, 2023-12: 3659, 2024-03: 4133, 2024-06: 4227, 2024-09: 4285, 2024-12: 4431, 2025-03: 4263,

Description: EG Everest

Everest Group Ltd is a global reinsurer and insurer operating through its subsidiaries, providing a range of insurance and reinsurance products across the United States, Europe, and other international markets. The company is structured into two main business segments: Insurance and Reinsurance, allowing it to diversify its offerings and risk exposure. Through these segments, Everest Group writes various types of reinsurance, including property and casualty, treaty, and facultative reinsurance, as well as specialty lines. It also provides direct insurance coverage for property and casualty through multiple distribution channels, including brokers, surplus lines, and general agents.

The companys product portfolio is diverse, including reinsurance products for mortgage, catastrophe, marine, aviation, and other specialized areas. This diversification helps in managing risk and capitalizing on opportunities across different sectors. Everest Groups insurance products are offered through various channels, including wholesale and retail brokers, surplus lines brokers, and program administrators, making its offerings accessible to a broad customer base. With its headquarters in Hamilton, Bermuda, and a history dating back to 1973, Everest Group has established itself as a significant player in the global insurance and reinsurance market.

From a technical analysis perspective, the stocks recent price movements indicate a relatively stable trend, with the last price being $343.82, slightly above its 20-day Simple Moving Average (SMA) of $343.42. However, it is below its 50-day SMA of $347.03 and significantly below its 200-day SMA of $359.31, suggesting a potential downward trend in the medium to long term. The Average True Range (ATR) of 7.88, or 2.29%, indicates moderate volatility. Given the current technical indicators and fundamental data such as a P/E ratio of 16.95 and a forward P/E of 6.81, a forecast could involve a potential buy signal if the stock price stabilizes above its 50-day SMA and shows signs of breaking through resistance levels.

Considering the fundamental data, Everest Groups market capitalization stands at $14.289 billion, with a Return on Equity (RoE) of 5.91%. The discrepancy between the current P/E and the forward P/E suggests anticipated growth or improved profitability. Using both technical and fundamental analysis, a potential forecast could be that if Everest Group Ltd can demonstrate a sustained recovery and break through its current resistance levels, coupled with an improvement in its RoE and maintaining a stable P/E ratio, the stock could see a positive trajectory in the coming months. A target price could be set around $380, based on a combination of its 52-week high of $400.34 and its current fundamental and technical indicators, representing a potential upside of about 10.5% from its current price.

Additional Sources for EG Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

EG Stock Overview

Market Cap in USD 14,497m
Sector Financial Services
Industry Insurance - Reinsurance
GiC Sub-Industry Reinsurance
IPO / Inception 1995-10-02

EG Stock Ratings

Growth Rating 42.9
Fundamental 35.7
Dividend Rating 62.3
Rel. Strength -27.9
Analysts 3.75 of 5
Fair Price Momentum 313.20 USD
Fair Price DCF 2318.28 USD

EG Dividends

Dividend Yield 12m 2.31%
Yield on Cost 5y 4.34%
Annual Growth 5y 4.56%
Payout Consistency 98.9%
Payout Ratio 41.0%

EG Growth Ratios

Growth Correlation 3m -45.4%
Growth Correlation 12m -74%
Growth Correlation 5y 87.9%
CAGR 5y 12.60%
CAGR/Max DD 5y 0.66
Sharpe Ratio 12m 0.30
Alpha -17.55
Beta 0.558
Volatility 24.75%
Current Volume 473.3k
Average Volume 20d 376.3k
What is the price of EG shares?
As of July 03, 2025, the stock is trading at USD 334.03 with a total of 473,274 shares traded.
Over the past week, the price has changed by -0.72%, over one month by -5.03%, over three months by -8.04% and over the past year by -7.65%.
Is Everest a good stock to buy?
Partly, yes. Based on ValueRay´s Fundamental Analyses, Everest (NYSE:EG) is currently (July 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 35.69 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of EG is around 313.20 USD . This means that EG is currently overvalued and has a potential downside of -6.24%.
Is EG a buy, sell or hold?
Everest has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold EG.
  • Strong Buy: 3
  • Buy: 3
  • Hold: 6
  • Sell: 0
  • Strong Sell: 0
What are the forecasts for EG share price target?
According to our own proprietary Forecast Model, EG Everest will be worth about 348 in July 2026. The stock is currently trading at 334.03. This means that the stock has a potential upside of +4.18%.
Issuer Target Up/Down from current
Wallstreet Target Price 400.8 20%
Analysts Target Price 399 19.4%
ValueRay Target Price 348 4.2%